Repository details

Liverpool COVID-19 Drug Interactions

Name of repository
Liverpool COVID-19 Drug Interactions
Repository URL
https://www.covid19-druginteractions.org/
Subject(s)
Description
The COVID-19 pandemic has affected every country in the world. It is well documented that those most susceptible to the worst outcomes of COVID-19 are the immunocompromised and those with underlying comorbidities. Therefore, patients requiring treatment for COVID-19 will also be on additional medication, posing a risk for drug-drug interactions (DDIs). In order to address this, the Liverpool Drug Interactions website team developed this freely available drug interactions resource to provide information on the likelihood of interactions between the experimental agents used for the treatment of COVID-19 and commonly prescribed co-medications.
Contact
  • covidpk@liverpool.ac.uk
Content type(s)
Keyword(s)
Persistent identifier(s) of the repository
  • biodbcore-001460
Repository type(s)
  • disciplinary
Mission statement for designated community
https://www.covid19-druginteractions.org/about
Research data repository language(s)
  • English
Data and/or service provider
  • data provider
Institution name
British HIV Association
Additional name(s)
  • BHIVA
Identifier(s)
  • ROR:01mzyze39
Country
United Kingdom
Type(s) of responsibility
  • funding
Type of institution
non-profit
Institution name
European AIDS Clinical Society
Additional name(s)
  • EACSociety
  • EACS
Identifier(s)
  • Wikidata:Q85759815
Country
European Union
Type(s) of responsibility
  • funding
Type of institution
non-profit
Institution name
More partners
Country
International
Type(s) of responsibility
  • sponsoring
Type of institution
commercial
Institution name
National Institute for Health Research
Additional name(s)
  • NIHR
Identifier(s)
  • ROR:0187kwz08
Country
United Kingdom
Type(s) of responsibility
  • funding
Type of institution
non-profit
Institution name
Radboud University Nijmegen Medical Centre
Additional name(s)
  • RUNMC
  • Radboudumc
Identifier(s)
  • ROR:05wg1m734
Country
Netherlands
Type(s) of responsibility
  • general
Type of institution
non-profit
Institution name
UK Research and Innovation
Additional name(s)
  • United Kingdom Resarch and Innovation
  • UKRI
Identifier(s)
  • ROR:001aqnf71
Country
United Kingdom
Type(s) of responsibility
  • funding
Type of institution
non-profit
Institution name
University of Basel
Identifier(s)
  • ROR:02s6k3f65
Country
Switzerland
Type(s) of responsibility
  • general
Type of institution
non-profit
Institution name
University of Liverpool, Centre of Excellence in Infectious Diseases Research
Additional name(s)
  • CEIDR
Country
United Kingdom
Type(s) of responsibility
  • general
Type of institution
non-profit
Institution name
University of Liverpool, Pharmacology Research Labs, Liverpool Drug Interactions Group
Country
United Kingdom
Type(s) of responsibility
  • general
Type of institution
non-profit

Policies (1)

Policy Name
Terms & Conditions

Database access

Type of access to research data repository
open

Data access (1)

Type of access to data
open

Data licenses (1)

DataLicense
Copyrights

Data upload (1)

Type of data upload
closed
Data citation guideline
https://www.covid19-druginteractions.org/prescribing-resources
Enhanced Publication
unknown
Quality management
unknown

Remarks

Entry date
2020-04-24
Last update
2021-01-07
Back to search
Submit a change request
Get a badge
The DataCite logo

Cite this re3data.org record:

re3data.org: Liverpool COVID-19 Drug Interactions; editing status 2021-01-07; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR7 last accessed: 2024-05-06